NeuroOne Medical Technologies Corporation
NMTC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,619 | -$1,501 | -$2,271 | $1,785 |
| Dep. & Amort. | $64 | $67 | $66 | $65 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $359 | $317 | $250 | $339 |
| Change in WC | -$246 | -$71 | $2,261 | -$1,944 |
| Other Non-Cash | -$84 | -$275 | -$363 | -$37 |
| Operating Cash Flow | -$1,526 | -$1,464 | -$56 | $208 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11 | -$44 | -$3 | -$24 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$11 | -$44 | -$3 | -$24 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $21 | $9,200 | $414 | -$21 |
| Stock Repurch. | $122 | -$3 | -$107 | -$11 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,671 | -$970 | -$62 | -$498 |
| Financing Cash Flow | -$7,821 | $8,226 | $245 | -$509 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,469 | $6,719 | $186 | -$326 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,040 | $1,320 | $1,134 | $1,460 |
| End Cash | $6,570 | $8,040 | $1,320 | $1,134 |
| Free Cash Flow | -$1,536 | -$1,507 | -$59 | $184 |